P

Poolbeg Pharma PLC
LSE:POLB

Watchlist Manager
Poolbeg Pharma PLC
LSE:POLB
Watchlist
Price: 4 GBX -2.44% Market Closed
Market Cap: 27.9m GBX

Intrinsic Value

The intrinsic value of one POLB stock under the Base Case scenario is 1.12 GBX. Compared to the current market price of 4 GBX, Poolbeg Pharma PLC is Overvalued by 72%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

POLB Intrinsic Value
1.12 GBX
Overvaluation 72%
Intrinsic Value
Price
P
Worst Case
Base Case
Best Case

Valuation History
Poolbeg Pharma PLC

What is Valuation History?
Ask AI Assistant
What other research platforms think about POLB?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is POLB valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Poolbeg Pharma PLC.

Explain Valuation
Compare POLB to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about POLB?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Revenue & Expenses Breakdown
Poolbeg Pharma PLC

Balance Sheet Decomposition
Poolbeg Pharma PLC

Current Assets 10.7m
Cash & Short-Term Investments 10m
Receivables 343k
Other Current Assets 395k
Non-Current Assets 1.7m
Intangibles 1.7m
Current Liabilities 429k
Accounts Payable 429k
Efficiency

Free Cash Flow Analysis
Poolbeg Pharma PLC

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Poolbeg Pharma PLC

Revenue
0 GBP
Operating Expenses
-5.9m GBP
Operating Income
-5.9m GBP
Other Expenses
221k GBP
Net Income
-5.7m GBP
Fundamental Scores

POLB Profitability Score
Profitability Due Diligence

Poolbeg Pharma PLC's profitability score is 26/100. The higher the profitability score, the more profitable the company is.

Low 3Y Average Gross Margin
Low 3Y Average Net Margin
Low 3Y Average Operating Margin
Negative ROE
26/100
Profitability
Score

Poolbeg Pharma PLC's profitability score is 26/100. The higher the profitability score, the more profitable the company is.

POLB Solvency Score
Solvency Due Diligence

Poolbeg Pharma PLC's solvency score is 81/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
Low D/E
81/100
Solvency
Score

Poolbeg Pharma PLC's solvency score is 81/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

POLB Price Targets Summary
Poolbeg Pharma PLC

Wall Street analysts forecast POLB stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for POLB is 19.38 GBX with a low forecast of 19.19 GBX and a high forecast of 19.95 GBX.

Lowest
Price Target
19.19 GBX
380% Upside
Average
Price Target
19.38 GBX
385% Upside
Highest
Price Target
19.95 GBX
399% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Poolbeg Pharma PLC
does not pay dividends
Shareholder Yield

Current shareholder yield for POLB is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y
What is the Intrinsic Value of one POLB stock?

The intrinsic value of one POLB stock under the Base Case scenario is 1.12 GBX.

Is POLB stock undervalued or overvalued?

Compared to the current market price of 4 GBX, Poolbeg Pharma PLC is Overvalued by 72%.

Back to Top